Nichols & Pratt Advisers LLP Novo Nordisk A S Transaction History

Nichols & Pratt Advisers LLP

  • $1.4 Billion
  • Q1 2025

A detailed history of Nichols & Pratt Advisers LLP transactions in Novo Nordisk A S stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 481,314 shares of NVO stock, worth $33.3 Million. This represents 2.38% of its overall portfolio holdings.

Number of Shares
481,314
Previous 477,879 0.72%
Holding current value
$33.3 Million
Previous $41.1 Million 18.7%
% of portfolio
2.38%
Previous 2.84%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025
BUY
$69.3 - $90.95 $238,045 - $312,413
3,435 Added 0.72%
481,314 $33.4 Million
Q4 2024

Feb 05, 2025
SELL
$85.0 - $120.04 $878,135 - $1.24 Million
-10,331 Reduced 2.12%
477,879 $41.1 Million
Q3 2024

Oct 25, 2024
SELL
$119.07 - $145.42 $953,155 - $1.16 Million
-8,005 Reduced 1.61%
488,210 $58.1 Million
Q2 2024

Jul 25, 2024
SELL
$122.71 - $146.91 $37,426 - $44,807
-305 Reduced 0.06%
496,215 $70.8 Million
Q1 2024

Apr 29, 2024
SELL
$102.11 - $135.92 $620,828 - $826,393
-6,080 Reduced 1.21%
496,520 $63.8 Million
Q4 2023

Feb 07, 2024
SELL
$87.78 - $105.45 $567,058 - $681,207
-6,460 Reduced 1.27%
502,600 $52 Million
Q3 2023

Nov 09, 2023
BUY
$90.94 - $199.54 $23 Million - $50.5 Million
253,140 Added 98.91%
509,060 $46.3 Million
Q2 2023

Aug 02, 2023
SELL
$155.98 - $172.65 $321,474 - $355,831
-2,061 Reduced 0.8%
255,920 $41.4 Million
Q1 2023

May 03, 2023
SELL
$132.34 - $159.14 $503,686 - $605,686
-3,806 Reduced 1.45%
257,981 $41.1 Million
Q4 2022

Feb 03, 2023
SELL
$102.55 - $135.33 $45,122 - $59,545
-440 Reduced 0.17%
261,787 $35.4 Million
Q3 2022

Nov 01, 2022
SELL
$95.28 - $116.93 $93,850 - $115,176
-985 Reduced 0.37%
262,227 $26.1 Million
Q2 2022

Aug 04, 2022
SELL
$103.24 - $121.81 $47,490 - $56,032
-460 Reduced 0.17%
263,212 $29.3 Million
Q1 2022

May 10, 2022
BUY
$93.1 - $112.54 $4,655 - $5,627
50 Added 0.02%
263,672 $29.3 Million
Q4 2021

Feb 08, 2022
SELL
$95.88 - $117.08 $26,367 - $32,197
-275 Reduced 0.1%
263,622 $29.5 Million
Q3 2021

Nov 01, 2021
SELL
$84.42 - $106.62 $3,798 - $4,797
-45 Reduced 0.02%
263,897 $25.3 Million
Q2 2021

Aug 09, 2021
BUY
$67.66 - $84.76 $11,163 - $13,985
165 Added 0.06%
263,942 $22.1 Million
Q1 2021

May 11, 2021
SELL
$67.06 - $75.82 $35,877 - $40,563
-535 Reduced 0.2%
263,777 $17.8 Million
Q4 2020

Feb 08, 2021
SELL
$63.89 - $73.8 $51,175 - $59,113
-801 Reduced 0.3%
264,312 $18.5 Million
Q3 2020

Nov 10, 2020
BUY
$63.69 - $70.22 $48,277 - $53,226
758 Added 0.29%
265,113 $18.4 Million
Q2 2020

Aug 10, 2020
SELL
$58.54 - $67.94 $81,077 - $94,096
-1,385 Reduced 0.52%
264,355 $17.3 Million
Q1 2020

Apr 24, 2020
BUY
$49.46 - $64.78 $89,720 - $117,510
1,814 Added 0.69%
265,740 $16 Million
Q4 2019

Feb 07, 2020
SELL
$49.86 - $58.26 $102,960 - $120,306
-2,065 Reduced 0.78%
263,926 $15.3 Million
Q3 2019

Nov 07, 2019
BUY
$47.54 - $53.43 $746,140 - $838,583
15,695 Added 6.27%
265,991 $13.7 Million
Q2 2019

Aug 05, 2019
BUY
$46.79 - $52.47 $187,300 - $210,037
4,003 Added 1.63%
250,296 $12.8 Million
Q1 2019

Apr 30, 2019
BUY
$46.36 - $52.63 $290,352 - $329,621
6,263 Added 2.61%
246,293 $12.9 Million
Q4 2018

Feb 08, 2019
BUY
$41.54 - $47.25 $403,104 - $458,514
9,704 Added 4.21%
240,030 $11.1 Million
Q3 2018

Nov 05, 2018
BUY
$46.76 - $51.24 $295,569 - $323,888
6,321 Added 2.82%
230,326 $10.8 Million
Q2 2018

Jul 27, 2018
BUY
$44.29 - $50.42 $336,604 - $383,192
7,600 Added 3.51%
224,005 $10.3 Million
Q4 2017

Feb 09, 2018
BUY
$47.53 - $53.73 $21,388 - $24,178
450 Added 0.21%
216,405 $11.6 Million
Q3 2017

Nov 08, 2017
SELL
$41.15 - $49.22 $41,150 - $49,220
-1,000 Reduced 0.46%
215,955 $10.4 Million
Q2 2017

Aug 08, 2017
BUY
N/A
216,955
216,955 $9.3 Million

Others Institutions Holding NVO

# of Institutions
1,839
Shares Held
339M
Call Options Held
12M
Put Options Held
10.6M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $156B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Nichols & Pratt Advisers LLP Portfolio

Follow Nichols & Pratt Advisers LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

News

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email